Background
==========

The orchestration of a successful immune response to infection requires an integrated tissue response coordinated by specific cytokine and chemokine release. Pathogen-specific immune responses are coordinated and dependent upon the activation of specific pathogen recognition receptors (PRRs), molecular moieties present upon sub-sets of leukocytes such as macrophages or dendritic cells. PRRs respond to pathogens or their PAMPs (*P*athogen *A*ssociated *M*olecular *P*atterns) by the initiation of distinct transcriptomic programmes which will dictate the cellular/tissue response \[[@B1]-[@B3]\]. In mammals different transcriptional programmes have been identified by microarray analysis for specific PAMPs (viral, bacteria and yeast) by both macrophages and dendritic cells which initiate the immune response by secreting molecules such as pro-inflammatory cytokines \[[@B4],[@B5]\].

The availability of salmonid-specific gene chips \[[@B6]-[@B8]\] has provided the means to begin to characterise the salmonid immune response at a global gene level both *in vitro*and *in vivo*. This technology will provide a deeper understanding of overall cellular and tissue processes during immune activation. A number of recent reports concerning PAMP recognition \[[@B9]\], activated macrophage transcriptomics \[[@B8]\] and immunomics \[[@B10]-[@B16]\] and genome-wide surveys \[[@B17]\] show that fish and fish macrophages clearly respond differentially to different pathogens. This therefore should lead to different physiological/immunological responses *in vivo*upon which the survival of the organism is based.

The head kidney or anterior kidney located posterior to the cranium, is the central hematopoietic organ in salmonids and other fish species. In addition, it contains adrenalin-producing chromaffin cells and also plays a major endocrine role in secretion of cortisol, the major glucocorticoid and mineralocorticoid in fish \[[@B18]-[@B21]\]. The head kidney can thus integrate the neuro-immuno-endocrine milieu in normal and pathological states. However, few global gene regulation studies concerning the molecular regulation of head kidney function during infection or PAMP stimulation in salmonids \[[@B15]\] have been reported although many studies have used this tissue as a primary source of macrophage-like cells for studies on the activation of the immune system \[[@B22],[@B23]\].

The *Novirhabdovirus*infectious hematopoietic necrosis virus (IHNV) is probably one of the most important fish viral pathogens, responsible for great mortalities in farmed salmonids \[[@B24],[@B25]\]. As for all the *Rhabdoviridae*, the genome of IHNV consists of a single-stranded negative-sense RNA which has been entirely sequenced \[[@B26],[@B27]\]. Their genome codes for five structural proteins: a nucleoprotein (N), a polymerase-associated protein (P), a matrix protein (M), an RNA-dependent RNA polymerase (L) and a surface glycoprotein (G) responsible for immunogenicity \[[@B28]-[@B30]\]. An additional gene, only present in some fish rhabdoviruses, located between the G and L genes, encodes a non-structural protein NV, whose putative role in virus replication remains to be fully evaluated \[[@B31]\] but appears to be linked to viral growth and pathogenicity \[[@B30]\]. The strong early immune response elicited by IHNV and other related RNA viruses has favored the development of several vaccines using a reverse genetics approach \[[@B32],[@B33]\]; however, recently a DNA vaccine against IHN has been registered in Canada (Novartis Animal Health Canada, Inc).

LPS, the major constituent of the external layer of the outer layer of Gram-negative bacteria, is a widely used PAMP-preparation which induces potent immune responses in which the lipid A portion of the molecule is primarily responsible for the endotoxic properties observed in experimental animals \[[@B34],[@B35]\]. Fish present a remarkable tolerance to LPS challenge in comparison to mammals which has been postulated to be due to differences in receptor-mediated recognition of LPS \[[@B36]\]. In vivo challenge to high concentrations of LPS in fish does not result in endotoxin-mediated mortality \[[@B23]\].

We have carried out *in vivo*challenges using either live or attenuated IHNV (infectious hematopoietic necrosis virus) or bacterial lipopolysaccharide (*E. coli*LPS) in trout (*Oncorhynchus mykiss*). Total RNAs from head kidney tissue were sampled, 1 and 3 days post intra-peritoneal injection (i.p.), and analysed by gene chip analysis. We have identified a generalised immune/stress/hematopoietic gene response to all treatments and a large set of viral-specific genes responding to IHNV infection. Gene ontology analysis presents two distinct physiological responses to either LPS or IHNV in which IHNV pathogenesis can be clearly identified. The response to LPS indicates a general inflammatory response followed by a significant hematopoietic response. Here we present a comparison of the differential gene expression patterns induced *in vivo*by a generic PAMP, *E. coli*LPS, and a viral pathogen, IHNV, and an attenuated form of the viral pathogen, attIHNV in the head kidney of the rainbow trout.

Results and Discussion
======================

Fish survival and pathogenesis
------------------------------

The epizootiology of IHN in young fish has been thoroughly described \[[@B27],[@B37]-[@B42]\] and includes widespread hemorrhages in kidney, liver and musculature leading to anemia, and extensive necrosis of major hematopioetic tissues (head kidney and spleen). No mortalities, external signs or histological lesions were observed in fish injected with IHNV or attIHNV at sampling time points. The remaining or non-sampled fish displayed the referred pathological features of IHN, arriving to a 100% mortality 7--9 days and 15--17 days after challenge with virulent or attenuated IHNV, respectively. In fish challenged with LPS no mortalities were recorded in experimental groups. This is a typical response in which fish do not show an appreciable \'septic shock\' type response. A molecular mechanism has been proposed addressing LPS-tolerance in fish which may be due to differential signalling from Toll-like receptors in which the classical TLR4 paradigm differs from that observed in mammals. In fact, rainbow trout macrophages have been shown to be about 1000 times less sensitive to LPS than mammalian macrophages \[[@B9]\].

Overview of viral and LPS-induced differential gene expression in the head kidney
---------------------------------------------------------------------------------

In order to examine the transcriptional profile of head kidneys (HK) dissected from trout treated with either intra-peritoneal LPS or infection with IHNV or attIHNV we used a salmonid-specific cDNA microarray platform previously validated for studies involving stress, toxicity and immune response in trout \[[@B6]-[@B8],[@B43]\].

Total numbers of genes significantly expressed in each of the treatments is shown in fig. [1](#F1){ref-type="fig"} and a list of 20 selected genes, ranked by the expression levels was included in tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}. Applying a selection criteria based in a classical cut-off value of \>2 fold change over the differentially expressed genes (*p*\< 0.01) emphasizes the stronger global induction of gene expression following the inoculation of both active and attenuated forms of IHNV (fig. [1b](#F1){ref-type="fig"}). Within differentially expressed gene groups (\>1 fold change, *p*\< 0.01; fig. [1a](#F1){ref-type="fig"}), bacterial LPS induces a higher response in comparison to viral groups. Although the number of ranked selected genes (*p*-value \< 0.01) is considerably lower than in viral treatments, about 56.5% (n = 58) and 60% (n = 45) of regulated genes at 24 and 72 hours respectively achieve more than 2 fold change in its expression levels, in contrast with attenuated (15%; n = 413 at 24 h and 25%; n = 591 at 72 h) or active (26%, n = 570 at 24 h and 35.5%; n = 428 at 72 h) viral inoculation of IHNV.

![**Gene response to lipolysaccharide and viral (active and attenuated IHNV) in the head kidney of trout (*O. mykiss*)**. **(a)**Total gene number (\>1 fold change; *p*\< 0.01) expressed on the microarray in each treatment and in each time point **(b)**Differentially expressed genes (p \< 0.01; FDR \< 0.05) with a 2-fold increase in expression levels are shown for each treatment and time point.](1471-2164-9-141-1){#F1}

###### 

List of top 20 up and down regulated genes in the head kidney of trout, 24 and 72 hours after i.p. injection of LPS. Genes were selected for significant differential expression at *p*\< 0.01 (FDR \< 0.05). Values are expressed as FC, fold change.

  **24 hours UP**                                                                          **72 hours UP**                                                                           
  ------------------- --------------------------------------------------- -------- ------- ------------------- ------------------------------------------------------------ -------- -------
  est03d11            Unknown-42                                          8.42     0.000   est03d11            Unknown-42                                                   3.81     0.000
  est04b01            Similar to rRNA (Vangl2)                            4.54     0.004   est03e02            Hypothetical-fish 15                                         3.39     0.001
  EXOB1_H05           Transposase-6                                       3.16     0.000   est04e04            MHC class 1b antigen                                         3.17     0.006
  EXOB2_D06           NADH dehydrogenase subunit 5-1                      2.76     0.000   EXOB2_H06           High affinity immunoglobulin epsilon receptor alpha          2.73     0.003
  est02g07            Ig mu heavy chain disease protein                   2.73     0.001   CA387837            Nucleolar protein NAP57                                      2.27     0.000
  est02a11            Ig kappa chain V-IV region B17-2                    2.71     0.002   EXOB4_C11           High affinity immunoglobulin gamma Fc receptor I precursor   2.15     0.008
  EST1-3A_G09         Unknown-75                                          2.32     0.001   ENH2_F09            Beta-2-microglobulin-1                                       1.99     0.004
  CA383564            Coatomer epsilon subunit 1                          2.25     0.001   EXOB2_A09           60S ribosomal protein L5-2                                   1.80     0.005
  est04e04            MHC class 1b antigen                                2.24     0.007   HST0001_C05         Cell division control protein 42 homolog                     1.72     0.009
  EST1-3A_F12         Transposase-59                                      2.12     0.001   EXOB3_F09           MHC class I heavy chain-1                                    1.71     0.001
  HK0002_D09          Prothymosin alpha                                   2.03     0.003   est01g04            5-aminolevulinate synthase                                   1.58     0.010
  est02e09            Ig heavy chain V-III region HIL                     2.00     0.005                                                                                             
  EXOB4_D12           Hpa repeat-1                                        1.99     0.001                                                                                             
  HK0003_E06          DnaJ homolog subfamily C member 9                   1.96     0.005                                                                                             
  HK0003_E08          Unknown-194                                         1.90     0.007                                                                                             
  est04g12            Envelope protein                                    1.90     0.004                                                                                             
  HK0002_H08          TATA-binding protein associated factor 2N           1.79     0.003                                                                                             
  CA387665            Cytochrome P450 2J2                                 1.79     0.000                                                                                             
  est01h01            Unknown-19                                          1.76     0.009                                                                                             
  est03b11            Acidic leucine-rich nuclear phosphoprotein 32 A-1   1.68     0.008                                                                                             
                                                                                                                                                                                     
  **24 hours DOWN**                                                                        **72 hours DOWN**                                                                         
                                                                                                                                                                                     
  EXOB2_D07           Ependymin related protein-1                         -2.28    0.002   est04c10            Unknown-56                                                   -2.04    0.000
  HST0001_C04         Hemoglobin alpha chain                              -2.42    0.004   CA367764            Calmodulin-1                                                 -2.13    0.001
  EST1-3A_D08         Glyceraldehyde-3-phosphate dehydrogenase-6          -2.49    0.009   est03c04            Matrix metalloproteinase-9                                   -2.21    0.000
  EXOB1_H06           CC chemokine SCYA110-2                              -2.55    0.005   HKT0001_E07         Actin, alpha skeletal 1                                      -2.28    0.002
  EST1-3A_H06         Transcription factor jun-B-1                        -2.89    0.003   est01f03            Deltex protein 1                                             -2.37    0.001
  est03f08            Transaldolase                                       -2.91    0.002   est01e02            Thymosin beta-4-1                                            -2.73    0.002
  EXOB2_H01           Unknown-100                                         -2.91    0.002   EXOB3_G05           Actin, cytoplasmic 2                                         -2.78    0.000
  est02f08            Serine protease-like protein-1                      -2.97    0.000   EST1-3A_D08         Glyceraldehyde-3-phosphate dehydrogenase-6                   -3.14    0.000
  EST1-3A_A09         Serine protease-like protein-2                      -3.96    0.003   EST1-3A_B03         Hypothetical-fish 44                                         -3.16    0.007
  CA371363            Glucose-6-phosphate isomerase-1                     -4.35    0.000   CA348284            CCAAT/enhancer binding protein beta                          -3.22    0.003
  HST0001_D08         Beta-globin                                         -4.46    0.000   CA374193            Chemokine receptor CXCR4                                     -3.71    0.000
  est04e05            Glutathione peroxidase-gastrointestinal             -4.54    0.000   utu04f08            Actin, alpha skeletal 5                                      -3.81    0.001
  est01c04            Unknown-11                                          -6.17    0.001   KVkm2_F01           Unknown-224                                                  -4.21    0.000
  EXOB2_D05           Matrix metalloproteinase 9-2                        -6.63    0.000   est01f01            DNA-binding protein inhibitor ID-1                           -4.64    0.000
  est01e10            Tolloid-like protein (nephrosin)-1                  -6.69    0.001   est02f08            Serine protease-like protein-1                               -4.64    0.001
  CA348284            CCAAT/enhancer binding protein beta                 -7.36    0.006   EST1-3A_A09         Serine protease-like protein-2                               -5.52    0.000
  est03c04            Matrix metalloproteinase-9                          -7.44    0.000   EXOB3_H01           Matrix metalloproteinase-13                                  -5.88    0.007
  EXOB2_G12           Tolloid-like protein (nephrosin)-2                  -9.26    0.000   EXOB2_H01           Unknown-100                                                  -12.08   0.000
  EST1-3A_B03         Hypothetical-fish 44                                -14.01   0.000   est01e10            Tolloid-like protein (nephrosin)-1                           -12.97   0.000
  EXOB3_H01           Matrix metalloproteinase-13                         -17.18   0.000   EXOB2_G12           Tolloid-like protein (nephrosin)-2                           -13.47   0.000

###### 

List of top 20 up and down regulated genes in the head kidney of trout, 24 and 72 hours after i.p. injection of attIHNV. Genes were selected for significant differential expression at *p*\< 0.01 (FDR \< 0.05). Values are expressed as FC, fold change.

  **24 hours UP**                                                                           **72 hours UP**                                                                
  ------------------- ----------------------------------------------------- ------- ------- ------------------- -------------------------------------------------- ------- -------
  EXOB2_B10           Hemoglobin beta chain                                 19.46   0.000   est03e08            Hypothetical-fish 36                               3.06    0.000
  HST0001_C04         Hemoglobin alpha chain                                11.19   0.000   CA343473            C3a anaphylatoxin chemotactic receptor             2.98    0.000
  KVkm2_A01           Unknown-219                                           10.93   0.000   EXOB2_G11           Stanniocalcin-1                                    2.93    0.000
  HST0001_D04         Alpha-globin I-2                                      10.93   0.000   EXOB1_B02           Hypothetical-fish 34                               2.84    0.000
  EXOB4_A03           Carbonic anhydrase                                    10.57   0.000   KVkm2_H07           Unknown-226                                        2.77    0.000
  CA366564            Huntingtin                                            8.52    0.000   EXOB3_A01           Unknown-103                                        2.73    0.000
  EXOB2_B12           RING finger protein 103                               8.34    0.000   CA363723            Cyclin C                                           2.64    0.000
  HST0001_C07         Unknown-213                                           7.60    0.000   EXOB4_H01           Unknown-132                                        2.63    0.000
  ENH2_E07            Unknown-3                                             7.04    0.000   est04c02            Unknown-53                                         2.61    0.000
  EXOB4_G09           Histone H14                                           6.94    0.000   HK0002_G04          Fructose-bisphosphate aldolase A                   2.45    0.000
  EXOB4_H06           Alpha-globin 1-3                                      6.63    0.000   EST1-3A_H03         Unknown-76                                         2.42    0.000
  utu01e09            Embryonic alpha-type globin2+collagen alpha 2(1)      4.94    0.000   CA358107            Ectonucleoside triphosphate diphosphohydrolase 1   2.42    0.000
  HK0002_G02          Creatine kinase, sarcomeric mitochondrial precursor   4.49    0.000   CA378361            Ubiquitin ligase SIAH1                             2.40    0.000
  HK0001_C08          Galectin-9 (VHSV-induced protein)-3                   4.14    0.000   HK0001_H12          Unknown-162                                        2.35    0.000
  CA361101            Regulator of G-protein signaling 1-2                  4.03    0.000   CA342204            TNF receptor associated factor 3                   2.33    0.000
  est02a11            Ig kappa chain V-IV region B17-2                      3.19    0.000   EST1-3A_H05         Adenosine deaminase 3                              2.31    0.000
  CA343473            C3a anaphylatoxin chemotactic receptor                3.00    0.000   est04f10            Hypothetical-fish 1                                2.30    0.000
  est04b01            Similar to rRNA (Vangl2)                              2.69    0.000   KVkm2_H11           Unknown-228                                        2.30    0.000
  HST0001_D02         ATP-binding cassette, sub-family F, member 2          2.58    0.000   HKT0001_A11         Hypothetical-fish 11                               2.28    0.000
  CA384134            G1/S-specific cyclin D2                               2.56    0.000   CA355893            DnaJ homolog subfami.B member 2                    2.26    0.000
                                                                                                                                                                           
  **24 hours DOWN**                                                                         **72 hours DOWN**                                                              
                                                                                                                                                                           
  est01e10            Tolloid-like protein (nephrosin)-1                    -2.60   0.000   EXOB2_G02           Profilin-1                                         -2.13   0.000
  est03c04            Matrix metalloproteinase-9                            -2.70   0.000   EXOB2_F12           60S ribosomal protein L7a-1                        -2.13   0.000
  HST0001_C03         Plasminogen precursor-2                               -2.72   0.000   est02g11            Cytochrome c oxidase subunit I-1                   -2.14   0.000
  KVkm2_H10           Unknown-227                                           -2.76   0.000   HK0001_H03          60S ribosomal protein L26                          -2.14   0.000
  CA34828             CCAAT/enhancer binding protein beta                   -3.05   0.000   HK0003_A12          Heterogeneous nuclear ribonucleoprotein A1-1       -2.16   0.000
  EXOB2_D05           Matrix metalloproteinase 9-2                          -3.07   0.000   EXOB1_H12           NADH dehydrogenase subunit 4                       -2.23   0.000
  est02f08            Serine protease-like protein-1                        -3.21   0.000   HK0002_D07          Unknown-172                                        -2.24   0.000
  EST1-3A_A09         Serine protease-like protein-2                        -3.25   0.000   EXOB3_G03           60S acidic ribosomal protein P2                    -2.31   0.000
  HK0003_C11          Tropomyosin alpha 3 chain-1                           -3.34   0.000   EXOB2_G09           Cytochrome c oxidase subunit I-2                   -2.34   0.000
  utu03e06            Parvalbumin alpha-3                                   -3.50   0.000   HST0001_D04         Alpha-globin I-2                                   -2.37   0.000
  CA370329            Lysozyme C precursor                                  -3.90   0.000   ENH2_H06            Unknown-5                                          -2.46   0.000
  HK0003_C08          Parvalbumin alpha-2                                   -3.99   0.000   est04c05            Ferritin heavy chain-1                             -2.54   0.000
  utu04h1             Myosin light chain 2-2                                -4.13   0.000   P_46                ATPase 6                                           -2.56   0.000
  utu02c02            Myosin heavy chain, skeletal, adult 1-1               -4.30   0.000   utu02b07            Cytochrome c oxidase subunit II                    -2.64   0.000
  Hete0002_A07        Metallothionein-IL                                    -4.49   0.000   KVkm2_H10           Unknown-227                                        -2.67   0.000
  HK0003_E07          Myosin light chain 2-1                                -4.49   0.000   EST1-3A_H07         Cytochrome b-1                                     -2.86   0.000
  HK0002_D07          Unknown-172                                           -5.04   0.000   est02h09            Nonhistone chromosomal protein HMG-17              -3.07   0.000
  EXOB1_A03           Metallothionein A                                     -5.05   0.000   CA370329            Lysozyme C precursor                               -3.08   0.000
  est01c04            Unknown-11                                            -6.17   0.000   EXOB1_C02           Unknown-83                                         -3.44   0.000
  HK0002_F05          Myosin heavy chain, skeletal, fetal                   -7.31   0.000   EXOB2_G01           Leukocyte cell-derived chemotaxin 2                -3.56   0.000

###### 

List of top 20 up and down regulated genes in the head kidney of trout, 24 and 72 hours after i.p. injection of active IHNV. Genes were selected for significant differential expression at *p*\< 0.01 (FDR \< 0.05). Values are expressed as FC, fold change.

  **24 hours UP**                                                                           **72 hours UP**                                                                   
  ------------------- ----------------------------------------------------- ------- ------- ------------------- ----------------------------------------------------- ------- -------
  CA343473            C3a anaphylatoxin chemotactic receptor                5.35    0.000   HST0001_D04         Alpha-globin I-2                                      15.48   0.000
  est04c02            Unknown-53                                            4.26    0.000   est02a11            Ig kappa chain V-IV region B17-2                      10.06   0.000
  est02b02            PEST-containing nuclear protein                       4.00    0.000   EXOB4_D02           Beta actin-2                                          9.60    0.000
  EXOB3_A01           Unknown-103                                           3.91    0.000   EXOB2_B10           Hemoglobin beta chain                                 9.58    0.000
  CA358107            Ectonucleoside triphosphate diphosphohydrolase 1      3.69    0.000   HK0003_A03          Thymosin beta-4-2                                     7.56    0.000
  EXOB4_H01           Unknown-132                                           3.63    0.000   est02f08            Serine protease-like protein-1                        6.41    0.000
  HK0002_G04          Fructose-bisphosphate aldolase A                      3.59    0.000   est02h09            Nonhistone chromosomal protein HMG-17                 6.00    0.000
  EXOB1_B03           Unknown-81                                            3.59    0.000   est03c04            Matrix metalloproteinase-9                            5.91    0.000
  EXOB4_E09           Hypoxanthine-guanine phosphoribosyltransferase        3.55    0.000   est01e06            Coronin-1B                                            5.51    0.000
  CA378361            Ubiquitin ligase SIAH1                                3.43    0.000   est02g07            Ig mu heavy chain disease protein                     5.44    0.000
  HK0003_G05          Unknown-201                                           3.43    0.000   EXOB4_H05           Unknown-133                                           5.24    0.000
  est04f10            Hypothetical-fish 1                                   3.41    0.000   est01e02            Thymosin beta-4-1                                     5.17    0.000
  EST1-3A_G03         Unknown-74                                            3.40    0.000   EXOB3_D02           Eukaryotic translation elongation factor 1 alpha 1    4.60    0.000
  CA378435            Protein phosphatase 2C delta isoform                  3.35    0.000   EXOB2_A01           MHC class II invariant chain-like protein 1           4.44    0.000
  HK0002_H10          Unknown-182                                           3.33    0.000   EXOB3_H01           Matrix metalloproteinase-13                           4.34    0.000
  EXOB1_F02           Transcription regulator protein BACH1                 3.28    0.000   EXOB1_A05           Ribosomal protein L6-1                                4.33    0.000
  est04b01            Similar to rRNA (Vangl2)                              3.26    0.000   EST1-3A_F05         Heat shock 70 kDa protein 1                           4.27    0.000
  EST1-3A_H05         Adenosine deaminase 3                                 3.21    0.000   EXOB2_G0            Profilin-1                                            4.00    0.000
  HK0001_H12          Unknown-162                                           3.05    0.000   HKT0001_H03         Microtubule-associated protein RP/EB                  3.95    0.000
  CA368716            Membrane-bound transcription factor site 2 protease   3.00    0.000   CA370329            Lysozyme C precursor                                  3.91    0.000
                                                                                                                                                                              
  **24 hours DOWN**                                                                         **72 hours DOWN**                                                                 
                                                                                                                                                                              
  utu01a03            40S ribosomal protein S3-1                            -3.22   0.000   EXOB1_B02           Hypothetical-fish 34                                  -4.48   0.000
  HKT0001_H03         Microtubule-associated protein RP/EB                  -3.24   0.000   HK0002_G04          Fructose-bisphosphate aldolase A                      -4.80   0.000
  utu04g05            40S ribosomal protein S9-3                            -3.27   0.000   CA384134            G1/S-specific cyclin D2                               -4.93   0.000
  EST1-3A_D03         60S ribosomal protein L23                             -3.32   0.000   EST1-3A_H03         Unknown-76                                            -5.18   0.000
  EXOB1_H08           ADP, ATP carrier protein 3                            -3.43   0.000   est03f04            F-box/WD-repeat protein 11                            -5.28   0.000
  EST1-3A_F05         Heat shock 70 kDa protein 1                           -3.54   0.000   CA368716            Membrane-bound transcription factor site 2 protease   -5.31   0.000
  EXOB1_A03           Metallothionein A                                     -3.55   0.000   CA384029            Chromobox protein homolog 4                           -5.47   0.000
  EXOB2_G09           Cytochrome c oxidase subunit I-2                      -3.55   0.000   EXOB3_A01           Unknown-103                                           -5.54   0.000
  HST0001_C03         Plasminogen precursor-2                               -3.56   0.000   EXOB4_H01           Unknown-132                                           -5.99   0.000
  EXOB3_E01           Na/K ATPase alpha subunit-2                           -3.76   0.000   EST1-3A_H05         Adenosine deaminase 3                                 -6.23   0.000
  HK0001_D01          Ubiquitin                                             -3.83   0.000   EXOB1_B03           Unknown-81                                            -6.29   0.000
  HK0002_B07          Heat shock 70kDa protein 8                            -4.24   0.000   HK0001_H12          Unknown-162                                           -6.44   0.000
  Hete0002_A07        Metallothionein-IL                                    -4.50   0.000   HK0002_H10          Unknown-182                                           -6.59   0.000
  utu02a08            Ubiquitin and ribosomal protein S27a-2                -4.43   0.000   est04c02            Unknown-53                                            -6.62   0.000
  est02a11            Ig kappa chain V-IV region B17-2                      -4.84   0.000   EXOB4_E09           Hypoxanthine-guanine phosphoribosyltransferase        -6.63   0.000
  utu02c02            Myosin heavy chain, skeletal, adult 1-1               -4.97   0.000   est02b02            PEST-containing nuclear protein                       -6.85   0.000
  utu04f11            40S ribosomal protein S3-2                            -6.00   0.000   est04f10            Hypothetical-fish 1                                   -7.01   0.000
  est03c10            Alanine-glyoxylate aminotransferase 2                 -7.41   0.000   EST1-3A_G03         Unknown-74                                            -7.55   0.000
  est01c04            Unknown-11                                            -8.11   0.000   CA378361            Ubiquitin ligase SIAH1                                -7.82   0.000
  HK0002_D07          Unknown-172                                           -8.74   0.000   EXOB2_G11           Stanniocalcin-1                                       -9.69   0.000

However, using the aforementioned selection criteria (\>2 fold change; *p*\< 0.01) the magnitude of the transcriptomic response, measured as the number of differentially expressed genes, shows a clear difference between active viral treatment and LPS, the former eliciting an extensive immune, apoptotic and transcriptional response (see the analysis of functional classes below; figs. [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}). As shown by the gene representation of the two viral treatments mirroring strength of induction at 1--1.5 fold change levels, transcriptomic responses also include an extensive repertoire of genes expressed below 1.5 fold with *p*\< 0.01 that clearly outnumber the 2-fold expressed genes (Fig. [1a](#F1){ref-type="fig"}) and can be ascribed to low-level transcriptional, metabolic and homeostasis maintenance programs (see tables [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"} and figs. [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}). Whilst it may be expected that an attenuated form of the virus does not induce a similar magnitude of response, the species-specific onset of the immune response elicited by the highly antigenic viral glycoprotein (G) of attIHNV may undoubtedly contribute to the observed gene expression pattern, as described in several DNA vaccination assays for fish pathogenic rhabdoviruses \[[@B14],[@B16],[@B33]\].

![**Over represented GO functional classes in LPS array experiments**. Functional categories with Yates corrected Chi squared *p*\< 0.05 were selected. Number of regulated genes for each category is shown in parenthesis.](1471-2164-9-141-2){#F2}

![**Over represented GO functional classes in attIHNV array experiments**. Functional categories with Yates corrected Chi squared *p*\< 0.05 were selected. Number of regulated genes for each category is shown in parenthesis](1471-2164-9-141-3){#F3}

![**Over represented GO functional classes in IHNV array experiments**. Functional categories with Yates corrected Chi squared *p*\< 0.05 were selected. Number of regulated genes for each category is shown in parenthesis.](1471-2164-9-141-4){#F4}

![**Gene Ontology analysis for LPS treatment**. Results show categories with significant difference, (pair comparison independent test, *p*\< 0.05), chosen from categories which had a p-value \< 0.01 from individual treatment groups. Data is shown as mean fold change ± std.error.](1471-2164-9-141-5){#F5}

![**Gene Ontology analysis for attIHNV treatment**. Results show categories with significant difference, (pair comparison independent test, *p*\< 0.05), chosen from categories which had a p-value \< 0.01 from individual treatment groups. Data is shown as mean fold change ± std.error.](1471-2164-9-141-6){#F6}

![**Gene Ontology analysis for IHNV treatment**. Results show categories with significant difference, (pair comparison independent test, *p*\< 0.05), chosen from categories which had a p-value \< 0.01 from individual treatment groups. Data is shown as mean fold change ± std.error.](1471-2164-9-141-7){#F7}

###### 

Genes common to all treatments. Genes selected were expressed in a minimum of 5 of the 6 experiments and compared against all experiments in the database (n = 155). Only genes specific to these experiments were chosen (Fischer\'s exact Test, *p*\< 0.01). Values are expressed as FC, fold change.

  **Clone ID**   **Clone Name**                                               **LPS (FC)**   **AttIHNV (FC)**   **IHNV (FC)**                   
  -------------- ------------------------------------------------------------ -------------- ------------------ --------------- ------- ------- -------
  CA384637       60 kDa heat shock protein-1                                  \-             1.47               1.18            1.25    -1.25   1.29
  est03b11       Acidic leucine-rich nuclear phosphoprotein 32 A-1            1.68           1.41               1.17            1.32    1.27    1.34
  utu01f04       Actin, alpha skeletal 2                                      \-             -1.31              -1.48           1.18    1.52    1.29
  utu01g11       Actin, alpha skeletal 3                                      1.67           -1.64              -1.47           -1.25   1.34    1.42
  utu04d04       Actin, alpha skeletal 4                                      2.00           -1.30              -1.18           \-      1.61    1.37
  EST1-3A_H05    Adenosine deaminase 3                                        1.57           \-                 1.14            2.31    3.21    -6.23
  HST0001_D04    Alpha-globin I-2                                             -1.30          \-                 10.93           -2.37   -3.11   15.48
  CA364941       Annexin A1-1                                                 -2.08          -1.78              -1.36           -1.46   -1.26   1.68
  F_122          ARP2/3 complex 21 kDa subunit                                \-             -.192              -1.41           -1.23   -1.57   1.33
  P_10           Aryl hydrocarbon receptor                                    1.35           \-                 1.32            1.80    1.47    -2.32
  CA367764       Calmodulin-1                                                 \-             -2.13              -1.26           -1.29   -1.73   1.49
  CA348284       CCAAT/enhancer binding protein beta                          -7.36          -3.22              -3.05           \-      -2.16   1.76
  CA363762       Cell death activator CIDE-B                                  1.32           \-                 1.35            1.74    2.08    -2.53
  CA383564       Coatomer epsilon subunit 1                                   2.25           \-                 1.20            1.43    1.24    1.53
  HK0003_G01     Creatine kinase, M-2                                         \-             1.61               -2.02           1.32    -1.54   -1.40
  HK0002_G02     Creatine kinase, sarcomeric mitochondrial precursor          -1.68          \-                 4.49            -1.54   -1.82   1.20
  CA358998       Cysteine-rich protein 1                                      -1.75          -2.71              -1.37           -1.51   -1.62   2.75
  utu01g04       Cytochrome oxidase subunit III-2                             \-             -1.36              -2.55           -2.04   -2.08   2.33
  EXOB1_C10      Cytochrome P450 2K4-2                                        1.60           1.34               1.20            -1.44   \-      -1.14
  utu01d06       Deoxyribonuclease gamma precursor                            1.50           \-                 -1.19           -1.26   1.46    -1.31
  utu01e09       Embryonic alpha-type globin2+collagen alpha 2(1)             -1.62          1.42               4.94            -1.41   -1.96   \-
  HK0001_D12     Estrogen-responsive B box protein                            1.29           \-                 -1.22           -1.14   2.11    -1.38
  HK0002_G04     Fructose-bisphosphate aldolase A                             1.65           \-                 1.25            2.45    3.59    -4.80
  HK0001_A11     Fumarate hydratase, mitochondrial precursor                  \-             -1.58              -1.12           -1.21   1.43    -1.25
  CA371363       Glucose-6-phosphate isomerase-1                              -4.35          -1.68              -1.40           -1.15   -1.37   2.81
  EXOB3_H05      Glucose-6-phosphate isomerase-2                              -2.07          \-                 -1.51           -2.08   -1.77   1.81
  CA366403       Heat shock 27 kDa protein-1                                  1.44           \-                 1.21            1.61    2.49    -2.43
  HST0001_C04    Hemoglobin alpha chain                                       -2.42          \-                 11.19           -1.82   -2.93   2.87
  EXOB2_B10      Hemoglobin beta chain                                        -1.86          \-                 19.46           -2.07   -2.45   9.58
  EXOB4_C11      High affinity immunoglobulin gamma Fc receptor I precursor   \-             2.15               -1.70           -1.73   -1.88   1.71
  est02a11       Ig kappa chain V-IV region B17-2                             2.71           \-                 3.19            -2.07   -4.84   10.06
  est02g07       Ig mu heavy chain disease protein                            2.73           \-                 2.38            1.56    -2.14   5.44
  EXOB2_D05      Matrix metalloproteinase 9-2                                 -6.63          -2.62              -3.07           1.71    -1.93   3.20
  EXOB3_H01      Matrix metalloproteinase-13                                  -17.18         -5.88              -1.32           2.06    1.44    4.34
  est03c04       Matrix metalloproteinase-9                                   -7.44          -2.21              -2.70           1.68    -2.92   5.91
  EXOB3_F09      MHC class I heavy chain-1                                    \-             1.71               -1.43           -1.20   -2.87   -3.02
  P_4            Myeloperoxidase                                              1.55           \-                 1.23            1.88    2.32    -3.19
  EXOB3_E09      N-myc downstream regulated protein-2                         -1.48          1.67               1.16            1.21    \-      -1.32
  EXOB2_G02      Profilin-1                                                   \-             -2.04              -1.79           -2.13   -2.12   4.00
  est02f08       Serine protease-like protein-1                               -2.97          -4.64              -3.21           1.32    -1.84   6.41
  EST1-3A_A09    Serine protease-like protein-2                               -3.96          -5.52              -3.25           1.32    -2.91   3.75
  HK0002_H08     TATA-binding protein associated factor 2N                    1.79           \-                 -1.32           -1.22   1.71    -1.32
  est01e02       Thymosin beta-4-1                                            \-             -2.73              -2.03           -1.32   -1.47   5.17
  est01e10       Tolloid-like protein (nephrosin)-1                           -6.69          -12.97             -2.60           -1.07   -3.11   2.98
  EXOB2_G12      Tolloid-like protein (nephrosin)-2                           -9.26          -13.47             -1.67           1.44    -1.75   3.70
  Hete0002_E09   Transposase-56                                               2.06           1.96               1.42            1.30    2.04    1.67
  EST1-3A_F12    Transposase-59                                               2.12           1.62               1.28            1.23    \-      1.20
  EXOB3_F11      Ubiquitin-conjugating enzyme E2-18 kDa                       \-             1.47               1.48            1.68    1.61    -1.84

###### 

Genes specific to viral treatments. Genes selected were expressed in a minimum of 3 of the 4 experiments and compared against all experiments in the database (n = 155). Only genes specific to these experiments were chosen (Fischer\'s exact Test, *p*\< 0.001). Values are expressed as FC, fold change. *13 Unknowns were removed*.

  **Clone ID**   **Clone Name**                                               **AttIHNV (FC)**   **IHNV (FC)**           
  -------------- ------------------------------------------------------------ ------------------ --------------- ------- -------
  CA387866       Arachidonate 5-lipoxygenase-2                                1.16               1.34            1.27    1.03
  CA384555       B-cell-specific coactivator OBF-1                            1.48               1.76            1.37    -1.09
  CA343473       C3a anaphylatoxin chemotactic receptor                       3.00               2.98            5.35    -1.50
  ENH2_F03       Cathepsin K-1                                                -2.30              1.22            -3.01   1.42
  EXOB4_F03      Cathepsin S                                                  -1.46              -1.28           -1.65   2.80
  CA376117       CD231                                                        1.31               1.55            2.04    -1.66
  CA363762       Cell death activator CIDE-B                                  1.35               1.74            2.08    -2.53
  EXOB4_E08      Cytochrome c oxidase subunit VIIa-related                    1.08               -1.14           1.18    -2.47
  CA381440       Double-stranded RNA-specific adenosine deaminase             1.45               1.53            1.69    -1.67
  CA351392       Guanine nucleotide exchange factor DBS                       1.19               1.93            2.97    -3.13
  EXOB4_C11      High affinity immunoglobulin gamma Fc receptor I precursor   -1.70              -1.73           -1.88   1.71
  HKT0001_A11    Hypothetical-fish 11                                         1.20               2.28            1.49    -1.85
  est03c07       Ig kappa chain V-I region WEA                                1.60               2.07            1.41    1.21
  est02g07       Ig mu heavy chain disease protein                            2.38               1.56            -2.14   5.44
  CA363978       Inhibitor of kappaB kinase gamma                             1.16               2.13            2.21    -2.36
  EXOB3_F09      MHC class I heavy chain-1                                    -1.43              -1.20           -2.87   -3.02
  CA341859       Nuclear factor NF-kappa-B                                    1.40               1.12            1.63    1.28
  CA378435       Protein phosphatase 2C delta isofor                          1.44               2.05            3.35    -3.87
  EXOB1_B07      PRPF39 protein                                               1.19               1.22            1.39    
  est03e10       Putative inorganic polyphosphate/ATP-NAD kinase              -1.11              -1.05           1.33    1.29
  est03b12       Secretory granule proteoglycan core protein                  -1.83              -1.83           -2.97   2.77
  ENH2_B08       Splicing factor, arginine/serine-rich 8                      1.10               1.24            1.25    -1.49
  CA380121       Telomerase reverse transcriptase                             1.33               1.36            1.34    -1.33
  EXOB1_G12      Thioredoxin                                                  -1.24              -1.61           -1.56   1.46
  CA342204       TNF receptor associated factor                               1.23               2.33            2.64    -2.89
  CA378736       Tyrosine-protein kinase BTK                                  1.28               1.61            1.81    -1.80
  EXOB3_G04      Tyrosine-protein kinase HCK                                  -1.07              -1.38           -1.39   1.40
  P_54           VEGF4                                                        1.23               1.34            1.37    

Not surprisingly, both viral treatments display a 10% increase in the number of genes regulated \>2 fold at 72 hours post-treatment. Previous studies on the pathogenicity of IHNV in salmonids typically describe a 24 h delay in detectable viral titres and internal measures of immunological disturbance, followed by a rapid increase in the differential expression of viral-related and acute phase response genes in major haematopoietic organs and liver, respectively \[[@B42],[@B44]\]. In addition, a tissue-specific effect determines the dynamics of the transient cellular populations during inflammation and, subsequently, the tissue-dependent gene expression profile. It has been suggested \[[@B45]\] that the transient double stranded RNA intermediates produced by the accelerated replication of IHNV 24 hours post infection seem to regulate the expression of trout Toll-like Receptor 3 (rtTLR3) in a unpredictable manner, strongly dependent on viral growth and host lymphocyte recirculation cycles. Interestingly, the pattern of rtTLR3 expression in response to *Yersinia ruckeri*, a gram-negative bacterial trout pathogen shows a remarkably lower magnitude in terms of fold change compared with the viral challenge \[[@B45]\], mimicking the magnitude of the response between LPS and IHNV/attIHNV treatments described above (fig [1b](#F1){ref-type="fig"}). Although both treatments display increases in the number of regulated genes the patterns of gene expression are also significantly different. The number of genes regulated show that LPS induces in the majority a down-regulation of gene expression at both time points. Similar results were observed in LPS-stimulated macrophages derived from trout, *O. mykiss*, analysed with the same platform \[[@B8]\]. Highest fold changes in individual genes were observed in down-regulated genes in the LPS groups (table [1](#T1){ref-type="table"}). On the other hand, viral treatments induce a higher induction of transcriptomic and cell cycle/apoptotic activity where induction and suppression processes display a similar weighting (tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

The viral treatments show the highest differential gene expression counts obtained when compared across all available experiments in our gene (KuopioChip) database. This observation, together with the extensive transcriptional onset observed in the analysis of functional ontology categories in viral treatments (see below), follows that of Abbas *et al*. (2006) suggesting that a specific immune response mobilizes more transcriptional remodelling than the majority of physiological responses.

Specific vs. common gene responses
----------------------------------

From the selected differentially expressed genes (*p*\< 0.01) in LPS and viral treatments, the differential response in LPS and viral treatments (significant differential expression in at least 5 of the 6 experiments) was evaluated across 155 experiments in our gene database (KuopioChip) in order to ascertain those genes co-expressed (Fischer\'s exact P \< 0.01) in each or both experimental conditions (minimum requirement was significant differential expression in at least 5 of the 6 experiments). A total of 49 genes were identified from which many genes showed opposite responses representative of directional responses to viral and LPS-induced stimuli (table [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}).

Interestingly genes regulated by the attIHNV treatment show a mixture of effects both similar and different to LPS and IHNV suggesting that different mechanisms, non-specific and specific response, of activation are induced by the attenuated virus in the head kidney. Alpha globin for example shows down regulation by LPS whereas attIHNV initially induces expression, 11 fold, followed by suppression, -2.37 fold. On the other hand IHNV causes suppression at 24 hours followed by strong induction, 15 fold. LPS and attIHNV show similar profiles for: Glucose-6-phosphate isomerase, annexin 1, the nephrosin proteins, calmodulin-1, CEBP-beta, cysteine-rich protein-1, cytochrome oxidase and cytochrome p-450. The majority of the genes are related to immunity and the inflammatory response. Suppression of HK proteases, nephrosin and MMPs, seems to be one of the most characteristic effects of LPS (Nephrosins FC; 24 hours; -6.69 and -9.26 and 72 hours -12.97 and -13.47) whereas viral treatment causes a similar initial effect followed by induction of expression (FC at 72 hours; attIHNV 1.44 and IHNV 2.98 and 3.7). Serine protease-like proteins 1 and 2(spl1 and spl2) are also highly suppressed by LPS, attIHNV and IHNV at 24 hours. This suppression continues in the LPS treatment, however in viral samples we observe a significant increase in expression in the 72 hour samples (attIHNV; 1.32 both spl1 and 2, IHNV; 6.4 and 3.75). Several cytoskeleton related genes including ARP2/3, the actin and profilin-1 are down-regulated by both LPS and attIHNV whereas IHNV induces up-regulation of all genes in this group at 72 hours post-infection.

Viral treatments induce a typical adaptive immune response (table [5](#T5){ref-type="table"}). The antigen processing/presenting loading pathways include the differential expression of MHC Class I and lymphoid and myeloid cell lineages, as shown by the regulation of B-cell specific coactivator OBF-1, essential for the response of B-cells to antigens and required for the formation of germinal centers, the conservation of BTK B-cell, HCK neutrophil and TNFalpha receptor signaling pathways, the cathepsin mediated antigen processing and the interferon-inducible RNA-specific adenosine deaminase ADAR1 (table [5](#T5){ref-type="table"}).

Not surprisingly, NF-kappa-B (NFkB) signal transduction suffered from moderate to severe regulation in the head kidney of infected trout (tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}). NFkB is considered a pleiotropic transcription factor expressed in several cell types undergoing amongst others inflammatory assaults. Both active IHNV and attIHNV treated fish showed differential regulation of Inhibitor of kappaB kinase gamma, member of a family of proteins which inactivate NFkB by trapping it in the cell cytoplasm \[[@B46]\] and are actively expressed in virus infected cells \[[@B47]\].

The anaphylactic arm of the complement activation acts in a double fashion through the component C3a/C3aReceptor: as a chemotactic mediator involved in endotoxic responses and, simultaneously, as a regulator of homing and mobilizations of hematopoietic stem cells (see below). Both complement related serine proteases (spl) and C3 proteolytic components were differentially expressed in LPS-induced or viral treatments. However, the highest levels of complement expression seem to be strongly dependent of viral invasions in fish head kidney (tables [3](#T3){ref-type="table"} and [5](#T5){ref-type="table"})

Stromal protease activity and extracellular matrix remodelling in trout head kidney
-----------------------------------------------------------------------------------

Although the precise function of nephrosin, an astacin metalloproteinase \[[@B48]\] remains unresolved, it has been shown to be involved in the late stages of granulocyte differentiation and cell migration and/or tissue infiltration processes in challenged carp and zebrafish \[[@B49],[@B50]\]. In trout treated with LPS, the two nephrosin proteins genes are severely down regulated (between -6 and -10 fold) at both time points (fig. [1](#F1){ref-type="fig"}). The rest of metalloproteinases (MMP 9-2, 13) also showed a marked decrease of expression in LPS treated trout (less than -6 fold change) at both time points and at 24 h in IHNV or attIHNV infected fish (-1.3 to -3 fold; see table [2](#T2){ref-type="table"} and additional file [1](#S1){ref-type="supplementary-material"}), therefore suggesting a decrease in extracellular matrix remodeling and leukocyte movement.

In mammals, MMP 9 has been implicated in the signal processing and maturation of dendritic cells, IL-8 mediated activation of neutrophils and undifferentiated hematopoietic stem cells \[[@B51],[@B52]\]. Whilst the existence of functionally differentiated dendritic cells in fish is still controversial \[[@B53],[@B54]\], the mammalian leukocyte response outlined for IL-8 and MMP 9 seems to be conserved in teleosts, although the exact pattern of organ distribution, the intensity of gene regulation and the voluble species-specific expression of IL-8 in fish HK remains obscure \[[@B55],[@B56]\]. The chemotatic properties of IL-8 on leukocytes are amplified by the recruitment of neutrophils mediated by CXC chemokines. Our data show a moderate (-3.71 fold change) down-regulation of trout CXCR4. Mammalian CXCR4 forms with TNFalpha, several HSP proteins and GDF5 an activation cluster involved in monocyte LPS signal transduction \[[@B57]\] and also acts synergistically with the colony-stimulating factor mediated mobilization of hematopoietic stem cells \[[@B57],[@B58]\].

The MMP gene family appears to be induced by LPS in trout macrophages \[[@B8]\], and a widescreen transcriptomic analysis of carp metalloproteinases detected a large amount of MMP9 mRNA mainly in hematopoietic organs, HK and spleen \[[@B59],[@B60]\]. Fish metalloproteinases thus probably act in a mammalian fashion, showing and up-regulation by the synergistic stimulation of Tumor Necrosis Factor alpha (TNFalpha) and LPS. In agreement with the low level expression of MMPs observed 24 h post injection, no significant amounts of TNFalpha mRNA were detected in LPS treated trout, in contrast with IHNV infected fish. Both myeloperoxidase, a lysosomal hemoprotein characteristic of mononuclear phagocytes, and TNF were up regulated 24 h post injection of attenuated IHNV in trout HK (2.3 and 2.6 fold, respectively). In the active viral group, however, TNFalpha was found to be inactive (see below). The moderate up-regulation of TNFalpha 3 days post attIHNV stimulation (table [2](#T2){ref-type="table"}) may suggest, according to the well described model of macrophage stimulation by LPS \[[@B8]\], the onset of a proliferative myeloid response in the principal hematopoietic organ.

Intracellular thymosin beta-4 (TBX4) is considered the main G-actin sequestering peptide in mammals \[[@B61]\]. The putative functions of extracellular TB4X include induction of hemostasis, wound and tissue healing, chemotaxis, induction of metalloproteinases, granulocyte-mediated inhibition of inflammatory processes and regulation of hematopoietic stem cell proliferation \[[@B62]\]. Not surprisingly, the TBX4 gene is \>2 fold down regulated in trout HK 72 h post injection of LPS (table [1](#T1){ref-type="table"}), but strongly upregulated (\>5--7 fold) in IHNV infected trout undergoing an incipient hemorrhagic symptomology. This suggests that, in fish as in mammals, the pleiotropic effects of TBX4 are mediated by the remodeling of intracellular actin cytoskeleton and/or components of the extracellular matrix \[[@B63]\].

The moderate/severe down-regulation of CXCR4 1 day post LPS challenge (-3.7 fold change), metalloproteinases and TB4X observed at 24 h and 72 h (less than -6 and -2 fold change levels, respectively; table [1](#T1){ref-type="table"}) thus favors a scenario of delayed reactive state to LPS stimulation in the recirculation and traffic of trout head kidney hematopoietic cells following i.p. administration of bacterial LPS. Moreover, the head kidney itself shows a low level stromal extracellular matrix remodeling in trout treated with LPS, as suggested by the down regulated expression of actin, MMP, nephrosins and Thymosin beta 4 (table [1](#T1){ref-type="table"}). However, at 3 days post IHNV infection the transcriptomic footprints in the head kidney reveal an immunological shift orientated toward a somewhat impaired adaptive arm activation coupled with a strong hemostatic and extracellular matrix sculpting response: the systemic spreading of IHNV clearly inhibits TNFalpha, MHC class I and several macrophage and cell cycle/differentiation markers (tables [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}; see below) favoring a MHC class II, immunoglobulin and MMP/TBX4 enhanced immune response.

Complement response to LPS-induced and viral challenges in trout head kidney
----------------------------------------------------------------------------

Contrary to the liver, the head kidney cannot be considered an acute phase reactive organ. Following a xenobiotic assault, complement related serine proteases, modulators and C3 proteolytic peptides are synthesized primarily in the liver. However, minor but biologically significant extra-hepatic (mainly in active immune cells, gills, skin, heart, gonad and renal tissues) synthesis of complement components has recently been demonstrated in fish as in other vertebrates \[[@B64],[@B65]\]. Therefore, complement inflammatory, chemotactic, opsonic and lytic activities extend the effect of the innate arm of immune responses to the core of major hematopoietic organs.

In trout injected with LPS, complement related serine proteases (spl1 and spl2) homologous to the MASP proteins involved in the activation of the classical complement pathway \[[@B66],[@B67]\] remained down regulated throughout the treatment (-3 and -4 fold change at 24 h and 72 h respectively; table [1](#T1){ref-type="table"}) and no expression of C3 genes were detectable in head kidney (table [1](#T1){ref-type="table"}), in concordance with the biased adaptive response observed in this group (see below). A recent microarray analysis of acute phase reactivity in the liver of catfish (*Ictalurus punctatus*) showed an enhanced (greater than \>2 fold) complement response in fish infected with *Edwardsiella ictaluri*, a gram negative pathogen responsible for enteric septicemia in catfish \[[@B13]\] In trout, Lovoll *et al*. (2007b) found a similar expression pattern in hepatocytes treated with LPS, but, in sharp contrast with the highest expression levels of complement genes in liver, a minor up regulation of C3 genes in head kidney and spleen was observed. Additionally, gene expression showed a strong tissue and isoform dependence: C3-4 was found to be down regulated in HK following stimulation with LPS, and more interestingly, not all trout isoforms maintained similar levels of gene expression \[[@B68]\].

The tolerance of fish to the standard LPS doses used in rodent immune challenges is well known, and has been linked to the peculiarities of PAMP receptors in fish \[[@B36]\] that may preclude a strong endotoxic shock response. Thus, the strongest cellular and tissue responses to i.p. injection LPS in fish are thought to be restricted to activated monocyte/macrophages and lymphocytes, portals of entry (gills, intestine, skin) and acute phase organs (liver). However, the *dynamics*of the teleostean immune response is of primary interest in these organs, as in the head kidney, that functions either as a cradle for immunological priming of leukocyte populations or as a major node in the complex and the still poorly understood network of neuro-immune-endocrine interactions in fish. In that respect, our results uncover a striking difference between lipopolysaccharide and viral treatments concerning head kidney transcriptomic dynamics: in attenuated and active IHNV groups, the complement related serine proteases and anaphylatoxin receptors (C3aR) maintain up regulated expression levels at both time points, with the maximal expression (\>5--6 fold change) in active viral groups.

The C3aR shows an unequivocal upregulated expression at 24 h and 72 h in animals infected with attIHNV, and at 24 h in animals infected with active IHNV (our results also show a tenuous down regulation of C3aR (-1.5 fold change) in IHNV treated fish at 72 h; see additional file [1](#S1){ref-type="supplementary-material"}). At 72 h, the response to IHNV consist of a mixture of adaptive (MHC, IG) and innate (C3aR, complement related serine proteases, lysozyme C) immune and stress (HSP70, hemostasis) responses against a background of metalloproteinase-mediated matrix remodeling (table [3](#T3){ref-type="table"}). Therefore, as suggested in this and previous studies with mammals \[[@B69]-[@B71]\], the expression of C3a/C3aR may probably contribute to the homing/mobilizations and differentiation of hematopoietic stem cells in response to the generalized immune and stress response elicited by an aggressive and extremely pathogenic virus in fish. Moreover, in mammals several C3 cleavage fragments, including C3a has been demonstrated to be linked to the CXCR4-mediated responsiveness of hematopoietic stem cells \[[@B71]\]. The moderate down regulation of CXCR4 in LPS treated fish (table [1](#T1){ref-type="table"}) and upregulation (\>1.5 fold) in attIHNV infected fish (see additional file [1](#S1){ref-type="supplementary-material"}), together with the strong upregulation of C3aR in IHNV treated fish suggests a conservation of complement mediated functional responses in the hematopoietic head kidney. The dynamics and trafficking of hematopoietic and differentiated cells in fish are, nonetheless, far from being fully understood.

Specific immune responses to LPS-induced and viral challenges in trout head kidney
----------------------------------------------------------------------------------

Genes involved in the immunoglobulin system increased in all treatments displaying different kinetics. Ig gamma Fc receptor (CD64) gene expression increased late in the LPS treatment whereas IgM heavy chain (B-cells) and Ig kappa chain V-IV region B17-2 (involved in antigen presentation) increased acutely. Under attIHNV conditions a similar regulation is observed for the latter genes in which IgM expression is sustained at 72 hours and Ig Kappa suppressed. CD64 expression is suppressed by attenuated virus, whereas IHNV suppresses all three genes at the early stage and induces expression (1.7, 10 and 5.4 fold respectively) at the later stage of infection. This may reflect migration of leukocytes to the primary sites of infection/inflammation and/or differential recruitment of leukocyte sub-populations to the infected head kidney in both IHNV/attIHNV treatments.

The coatomer protein (COP) epsilon known to play a role in the formation and maturation of phagosomes \[[@B72]\] is induced in all treatments, and the Class I major histocompatibility complex (MHC) antigen, well known to be involved in antigen presentation in dendritic cells is activated late by LPS and suppressed by viral treatments (-3 fold; tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}), whereas Class II MHC showed a moderate up regulation (4.4 fold) in fish infected with IHNV at 72 h.

In fish, as in mammals, the interaction of MHC molecules with T cell receptors (TCR) seems to activate subsets of cytotoxic T lymphocytes (CTL) and T helper cells (Th) in a similar fashion \[[@B73]\]. Homologues of mammalian MHC, several proteins associated to antigen presentation, beta2 microglobulin and CD8+ and CD4+ (markers for CTL and Th, respectively) have been recently characterized in trout and other fish species \[[@B74],[@B75]\], thus reinforcing the conservation of antigen processing pathways in immune cells. However, the trafficking, recirculation and cell-to-cell communication against a quiescent/activated immune background have not yet been properly described in fish. Moreover, the translation of classical bacterial or viral inflammatory murine models encompasses several technical (full characterization of immune processes, absence/presence of mediators, conservation of activation/inhibition pathways) and species-specific difficulties, the latter related to the high variability of the interspecific thresholds of immune activation in fish and, last but not least, the relative virulence and co-evolutionary trade-offs of pathogens.

Our and several recent studies have attempted to resolve these issues weighting the organ related immune response to an established model of LPS-induced inflammation or viral infection. In this regard, the expression of CD8 and CD4 (coreceptors of MHC Class I and II binding, respectively) in trout seems to be restricted mainly to thymus and to a certain extent, to spleen, even though non-infected fish maintain a widespread low level expression in several hematopoietic or lymphocyte infiltrated organs \[[@B74],[@B75]\]. Overturf and LaPatra (2006) were unable to find elevated levels of CD8 expression in the HK of trout infected with bacteria or IHNV at 24 h or 5 days post infection, although in liver and spleen a positive dose-response correlation followed the infection (24 h) expression of CD8 and C3 \[[@B76]\]. In a similar experiment, 72 hours after IHNV challenge Hansen and LaPatra (2002) observed a surprising tissue-specific shutdown of MHC Class IIB mRNA in head kidney and spleen of infected trout, thus suggesting an enhanced CD8 response coupled with activation of MHC Class I antigen presentation following IHNV infection \[[@B77]\], as observed in a cohabitant model of fish viral infection described recently \[[@B78]\]. Similarly, an infection by *Vibrio anguilarum*seemed to depress the short term (up to 4 days) expression of MHC class II genes in head kidney, liver and spleen of turbot, *Scophthalmus maximus*\[[@B79]\]. However, an elevated expression of MHC Class II genes has been described in trout following i.m. DNA vaccination with recombinant IHNV \[[@B80]\] and xenobiotic inflammation \[[@B81]\]. In trout challenged with VSHV, a member of Rhabdoviridae, the dynamics of T cell expansion, and thus the onset of MHC mediated adaptive immune response, were found to be correlated with the expected waves of viral replication, with peak a week after viral challenge \[[@B82]\], mimicking the delayed (up to 10 days) expression of MHC mRNAs that were also observed in japanese flounder (*Paralichthys olivaceus*) leukocytes infected with *Neoheterobothrium hirame*, a monogenean parasite \[[@B83]\].

As described in other species \[[@B84],[@B85]\], our results suggest a predilection for CD4/Th lymphocyte response in the head kidney of trout challenged with IHNV at 72 post infection, coupled with a strong spl-induced complement cleavage activation and MMP/TBX4 extracellular matrix sculpting, together with a decreased TNFalpha mediated activation of monocyte/macrophage populations, a shutdown of MHC Class I and also a low level regulation of apoptosis, as shown by the inhibition of Ubiquitin ligase S1AH1 and Galectin-9 (see table [3](#T3){ref-type="table"} and additional file [1](#S1){ref-type="supplementary-material"}).

The i.p. administration of LPS activates the MHC Class I pathway of antigen processing in concordance with previous studies with LPS-activated trout macrophages \[[@B8]\]. However, the transcription factor CCAAT/enhancer binding protein-alpha (C/EBP-alpha), best known for its role in driving myeloid cells towards the granulocytic line \[[@B86]\] but also known to be induced during macrophage differentiation, and the MMP/TBX4 response was inhibited in head kidney 72 h post injection. Deltex protein 1 (DTX) also appears to be down regulated 72 h post infection with LPS (table [1](#T1){ref-type="table"}). Although still poorly understood, the cross-talk between Deltex protein 1 (DTX1) and the evolutionary conserved Notch and NFkappaB signaling pathways \[[@B87],[@B88]\] allows the normal development and maturation of differentiated lymphocyte populations in hematopoietic and lymphopoietic organs in mammals. This suggests an impaired trafficking of lymphoid/myeloid HK cells in the early response to LPS in trout.

Myeloperoxidase (MPO) was up-regulated by all treatments at 24 hours returning to baseline in LPS samples, increasing in attIHNV and actively inhibited in IHNV samples (tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}). Myeloperoxidase is expressed in neutrophils and monocytes and plays a role in the oxygen dependent mechanism of phagocytosis. The macrophage scavenger receptor MARCO \[[@B89]\] was also inhibited in IHNV samples. Therefore, the microbiocidal function was diminished in the head kidney of IHNV infected trout.

Taken together, these results may suggest a minor function of the head kidney in the *short term*(24--72 hrs) activation of the immune response to virulent IHNV, or, alternatively, an inducible and maybe antagonistic early differential expression of MHC Class I or II mediated antigen processing in the head kidney, heavily influenced either by the type and infective dynamics of pathogen (LPS vs. viral) or the portals of entry (organ/tissue). From the experimental infections described above, the liver and spleen also seem to act as a major acute phase reactive organs at the initial stages of viral invasion, and the head kidney can be more properly defined as an inductor of a delayed adaptive response as much as a major regulator of erythropoietic and myeloid differentiation. Nevertheless the dual expression of the MHC antigen processing/presenting machinery appears to be strongly influenced by the species-specific immunological sensibility \[[@B90],[@B91]\], the virulence of pathogens and the timing of cellular differentiation in immune organs. This pathogen/host species-specific branching of MHC mediated immune response in fish requires, however, further analysis.

Haemoglobin metabolism in LPS-induced and viral infected trout head kidney
--------------------------------------------------------------------------

Hemoglobin genes (α, β) are suppressed by both LPS and IHNV at 24 hours, 2--3 fold suppression, however attIHNV strongly induces expression of both proteins(11 and 19 fold respectively) followed by suppression at 72 hours. IHNV induces expression (3 and 10 fold α and β respectively) at 72 hours whereas LPS samples return to baseline levels.

Interestingly, 5-aminolevulinate synthase, the key enzyme involved in heme synthesis was up-regulated in both attIHNV samples and in a LPS-specific manner at 72 hours. A similar response has been observed in head kidney tissue from Atlantic salmon, *S. salar*, infected with Piscirickettsia \[[@B15]\].

The coordinated expression of both hemoglobin genes and 5-aminolevulinate synthase suggest erythropoietic activity in the head kidney. Furthermore, a significant increase in cellular proliferation in PU-1-ve cells, 72 hours post-LPS administration, in the head kidney of LPS-treated rainbow trout has been reported (Ribas et al, 2007 *in press*) thus activation of hematopoietic, potentially erythropoietic, mechanisms during the early stages of infectious processes may be a standard for the non-specific immune response in fish.

HSP induced stress response to LPS-induced and viral challenges in trout head kidney
------------------------------------------------------------------------------------

Active IHNV inhibits the expression of heat shock protein (HSP) 27 (-2.4 fold) and induces the expression of 70 and 90 (2.8 and 2.3 fold respectively) 3 days post infection from a previous inactive state at 24 h (-4.24 fold). The attIHNV showed a down regulation of HSP70 (-2 fold) at the same time point.

HSPs have been implicated in the generalized stress response associated to xenobiotics and/or inflammatory reactions in fish \[[@B44],[@B85],[@B92]\]. However, the reliability of HSP as an indicator of stress or pathologic/immune disturbances has recently thoroughly criticized \[[@B93]\] because of the great variability of measured HSP expression: despite the correlated expression of HSP with altered states in stressed or injured fish, the sensitivity and intensity of HSP response can vary in a species-specific manner, and among tissues, HSP families, season, developmental stages and stressor. Not being an acute phase response organ, it is, thus, difficult to speculate about the fate of HSP repaired enzymatic and/or cytoskeleton proteins in infected head kidney.

Conclusion
==========

For the functional analysis of biological roles of regulated genes, our two-step approach in the first instance establishes a list of differentially expressed genes whose ascribed biological roles are evaluated and secondly by identifying overrepresented GO functional categories using the KuopioChip analysis software (see materials and methods). This methodological approach is not exempt of limitations. The selected cut-offs for minimal gene expression, the co-expressed patterns of gene expression, the non lineal genome-proteome crosstalk and the limited transcript enrichment of the array can either limit the amount and quality of transcriptomic responses assessed or exclude transient but biologically relevant genetic responses correlated with the abruptness and organ-dependent systemic damage in infected fish.

As a guideline for elucidating the biological response of viral/LPS-induced challenge, the comparison of differentially expressed genes by the GO categories showed a marked induction of metalloproteinases and other collagen and extracellular matrix sculptors in LPS treated trout, coupled with a decrease in genes controlling the basal metabolism and an increase in the activity of immune related mediators of MHC antigen presenting and immunoglublin-mediated opsonisation (figures [2](#F2){ref-type="fig"} and [5](#F5){ref-type="fig"}) 72 h post infection.

Several genes involved in signal transduction and protein biosynthesis were active in attIHNV groups 72 h post infection, following a decrease in cytoskeleton remodelling. As in active IHNV infected trout, the functional GO categories are strongly enriched in genes active during inflammatory, immune and defence responses. In both attenuated and active IHNV treated fish, the immune response at 72 h clearly outweighs the metalloproteinase orientated LPS response, but, as described above, the response of the trout head kidney transcriptome to IHNV infection was more robust and diversified in number and immune related activation pathways.

Methods
=======

Animal protocol an experimental infections
------------------------------------------

Rainbow trout, *Oncorhynchus mykiss*, were obtained from two commercial fish farms. Fish were maintained in flow through tanks under ambient conditions of light (photoperiod 10L/14D) and temperature (15 ± 2°C). Fish were fed with commercial trout pellets *ad libitum*and acclimated for at least two weeks prior to use in experiments. The health status of the animals and water quality were checked on a daily basis. Challenge experiments were carried out separately for each treatment and were performed in recirculating tanks with aeration at 14°C. Trout (n = 10/tank) weighing between 70--100 g were separated into 6 different tanks, 3 control and 3 experimental tanks. For experimental stimulations the fish were mildly anaesthetized (MS-222, 40 ppm, stage II of anaesthesia according to Iwama et al. 1989) and intraperitoneal (i.p.) injections carried out. Fish were intraperitoneally injected with saline (control) and LPS (6 mg/Kg; serotype 026:B6, Sigma, \#L-8274), or with 100 μl of a 10^6^pfu/ml dilution of IHNV or attIHNV or culture medium (negative control). At defined time points, 24 and 72 hours post i.p. injection, animals (total n = 6), control and experimental, were selected from each tank (n = 2) and sacrificed by over anesthetization (MS-222, 100 ppm, stage III of anaesthesia \[[@B94]\]). Head kidneys (HK) were immediately dissected out, pooled and processed for total RNA purification using Tri Reagent (Molecular Research Center, Cincinnati, OH, USA) according to the manufacturer\'s protocol \[[@B95],[@B96]\].

Viruses and cell line
---------------------

IHNV (French isolate 32/87) was used and propagated in the fish epithelial cell-line EPC derived from common carp (*Cyprinus carpio*) \[[@B97]\]. EPC cells were cultured in Eagle\'s minimum essential medium (MEM, Gibco) supplemented with foetal bovine serum (FBS), penicillin (100 IU ml^-1^), streptomycin (100 μg ml^-1^), buffered with 7,5% sodium bicarbonate and incubated at 20°C. The virus was inoculated on EPC grown in MEM with antibiotics and 2% FCS at 14°C. When the cytopathic effect was complete, the supernatant was harvested and centrifuged to eliminate cell debris. The virus stock was titrated according to Reed & Muench \[[@B98]\] in EPC 96 well plates. Attenuated IHNV was generated by reverse genetic engineering of virulent IHNV by M. Bremont as described elsewhere \[[@B31]\].

RNA isolation
-------------

RNA from head kidneys of experimental and control/sham-injected fish were extracted with the Trizol reagent (Life Technologies) or Tri Reagent (Molecular Research Center, Cincinnati, OH, USA) according to the manufacturer\'s instructions. DNase treatment was performed to remove contaminating DNA from preparations. RNA was precipitated using ethanol 100% and ammonium acetate (pH 5.2). The RNA was stored at -80°C in ethanol 70% until use.

Microarray design and analyses
------------------------------

The design of the microarray is described in detail elsewhere \[[@B6],[@B7]\] and a full description of the platform and data presented in this manuscript are accessible through the public GEO depositories (accession number GPL6155 and GSE10272). In brief, the platform included 1380 genes printed in six replicates each. Random clones from common and subtracted cDNA libraries (976) were compared with the known vertebrate proteins using blastx and 686 genes were identified; the functional annotations were transferred from the putative homologs. These clones were supplemented with 297 genes selected by the categories of Gene Ontology. Overall, each microarray was enriched in a number of functional classes, such as stress and defense response (145 and 105 genes, respectively), cell cycle (62 genes), signal transduction (114 genes), chaperone activity (41 genes), and apoptosis (79 genes).

Total RNA obtained from head kidney tissue was verified for quantity and integrity by denaturing electrophoresis and labeling with Cy3- and Cy5-dCTP (Amersham Pharmacia) was completed using SuperScript III reverse transcriptase (Invitrogen) and oligo(dT) primer, and cDNA was purified with Microcon YM30 (Millipore). We used a dye swap experimental design \[[@B99]\] and each sample was hybridized to two microarrays. For the first slide, test and control cDNA were labeled with Cy5 and Cy3 respectively, and for the second array dye assignment was reversed. All head kidney samples were analyses using the dye swap protocol. The slides were pre-treated with 1% BSA, fraction V, 5 × SSC, 0.1% SDS (30 min at 50°C) and washed with 2 × SSC (3 min) and 0.2 × SSC (3 min) and hybridized overnight in cocktail containing 1.3 × Denhardt\'s, 3 × SSC 0.3% SDS, 2.1 μg/μl polyadenylate and 1 μg/μl yeast tRNA. All chemicals were from Sigma-Aldrich. Scanning was performed with ScanArray 5000 and images were processed with QuantArray (GSI Luminomics). The measurements in spots were filtered by criteria *I*/*B*≥ 3 and (*I*-*B*)/(*S*~*I*~+ *S*~*B*~) ≥ 0.6, where *I*and *B*are the mean signal and background intensities and *S*~*I*~, *S*~*B*~are the standard deviations. After subtraction of mean background, locally weighted non-linear regression (Lowess) normalization \[[@B100]\] was performed separately for each slide. To assess differential expression of genes, the normalized log intensity ratios were analyzed with Student\'s t-test (*p*\< 0.01). The Bayesian modification to the false discovery rate (FDR) was used to correct for multiple comparison tests, estimating the *q*-value for the set of differentially expressed genes \[[@B101]\]. For the analysis of the functional profiling of samples, all genes that showed significant differential expression (*p*\< 0.01) in at least one sample were used. Due to the large number of genes, the statistical significance of over represented functional categories in each experiment (figs. [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}) was assessed using the Yates correction to Chi square test (corrected *p*\< 0.05). The log (*p*-level) ranked up or down-regulated genes were analyzed interrogating the functional classes of Gene Ontology (GO) \[[@B102]\] and compared by the sums of ranked genes (Student\'s t-test, p \< 0.05). A list of LPS and virus specific responsive genes (figs [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}) was obtained by GO data mining of a database (KuopioChip) of 155 previous immune and stress related experiments \[[@B7],[@B43]\].

Quantitative RT PCR
-------------------

Primers were designed to amplify 194--305 bp fragments. RNA was processed with Rnase-free Dnase (Promega). Synthesis of cDNA with Superscript III reverse transcriptase (Invitrogen) was primed with oligo(dT). Analyses were carried out using Dynamo SYBR Green kit (Finnzymes) and ABI Prism 7700 (Amersham-Pharmacia)

In order to quantify mRNA expression, real time PCR (Q-PCR) was carried out. cDNA was diluted 1:50 for target mRNA and 1:100 for 18S and used as a template with the primers Q-PCR Fw and Q-PCR Rv (see additional file [1](#S1){ref-type="supplementary-material"}, table 7). Wells (20 μl final volume) contained 10 μl of iQ™ SYBR Green Supermix (Bio-Rad), 500 nM concentration of forward and reverse primers and 5 μl of cDNA. Controls lacking cDNA and controls containing RNA were included. Reactions were run in a MyiQ thermocycler (BioRad) under the following protocol: 5 min initial denaturation at 95°C, followed by 40 cycles of 10 sec denaturation at 95°C and 30 sec at 60°C, and a final melting curve of 81 cycles (from 55°C to 95°C). All samples were run in triplicate and fluorescence was measured at the end of every extension step. C~T~(threshold cycle) values for each sample were expressed as \"fold differences\", calculated relative to untreated controls and normalized for each gene against those obtained for 18S (see additional file [1](#S1){ref-type="supplementary-material"}, Table 8).
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